Loading news...
NEW YORK, Feb. 2, 2026 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who hold stock of FONAR Corporation ("FONR" or the "Company") (NASDAQ: FONR). You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into potential breaches of fiduciary duty by the officers and directors of FONAR Corporation.
Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and Fonar (NASDAQ: FONR - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Insider and Institutional Ownership 50.6% of Fonar
PHILADELPHIA, Jan. 27, 2026 /PRNewswire/ -- Investor protection firm Kaskela Law LLC is investigating the proposed buyout of FONAR Corp. (NASDAQ: FONR) ("FONAR") to determine whether the proposed buyout price materially undervalues the company's shares and shortchanges the company's investors. Click here for additional information: https://kaskelalaw.com/case/fonar-corp/ On December 29, 2025, FONAR announced that it had agreed to be acquired at a price of $19.00 per share in cash.
NEW YORK and NEW ORLEANS, Jan. 23, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
NEW YORK, Jan. 21, 2026 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who hold stock of FONAR Corporation ("FONR" or the "Company") (NASDAQ: FONR). You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into potential breaches of fiduciary duty by the officers and directors of FONAR Corporation.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
NEW YORK, Jan. 17, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: FONAR Corporation (NASDAQ: FONR)'s sale to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company for $19.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: FONAR Corporation (NASDAQ: FONR)'s sale to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company for $19.
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.
NEW YORK, Jan. 5, 2026 /PRNewswire/ --Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating FONAR Corporation (NASDAQ: FONR ) related to its sale to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company.
MILWAUKEE, Dec. 31, 2025 /PRNewswire/ -- Ademi LLP is investigating FONAR (NASDAQ: FONR) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Timothy Damadian and an acquisition group consisting of certain members of the FONAR's management team and board of directors and third parties. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of FONAR Corporation (NasdaqCM: FONR) to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company. Under the terms of the proposed transaction, shareholders of FONAR will receive $19.00 per share of the Company's common stock, $19.00 per share of the Co.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of FONAR Corporation (NASDAQ: FONR) to affiliates of Chief Executive Officer Timothy Damadian and certain executives and directors of the company for $19.00 per share for FONAR's Class B common stock, and $6.34 per share for FONAR's Class C common stock, is fair to FONAR shareholders. Halper Sadeh encourages FONAR shareholders to click here to learn more about their legal rights and optio.
U.S. stock futures swung between gains and losses on Tuesday after Monday's declines. Futures of major benchmark indices were mixed.
U.S. stock futures swung between gains and losses on Tuesday after Monday's declines. Futures of major benchmark indices were mixed. The Santa Claus rally, which began on Dec. 24 last week, seems to have resumed gains after a day of losses on Monday.
U.S. stock futures mixed on Tuesday, potential stocks to watch: TEN Holdings up 17%, Fonar up 24%, CapsoVision down 11%.
FONAR stockholders to receive $19.00 per share of common stock, in an all-cash transaction Melville, New York--(Newsfile Corp. - December 29, 2025) - FONAR Corporation (NASDAQ: FONR) ("FONAR" or the "Company"), The Inventor of MR Scanning™, today confirmed that it entered into a definitive agreement on December 23, 2025 (the "Merger Agreement") with FONAR, LLC and FONAR Acquisition Sub, Inc. (collectively, "Buyer"), under which, subject to the satisfaction of the conditions set forth in the Merger Agreement, Buyer will acquire all of the issued and outstanding shares of the Company (other than shares owned by Buyer, the members of the Acquisition Group or shares held in treasury by the Company or its direct or indirect subsidiaries), for an amount in cash equal to $19.00 per share of the Company's common stock, $19.00 per share of the Company's Class B common stock, $6.34 per share of the Company's Class C common stock and $10.50 per share of the Company's Class A non-voting preferred stock (the "Transaction"). Buyer is controlled by the previously disclosed acquisition group led by Chief Executive Officer Timothy Damadian and consisting of certain members of the Company's management team and board of directors (the "Board") and third parties (collectively, the "Acquisition Group").
Global Wholehealth Partners (OTCMKTS:GWHP - Get Free Report) and Fonar (NASDAQ: FONR - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, dividends, risk, institutional ownership, profitability and valuation. Institutional and Insider Ownership 50.6% of Fonar shares
FONR reports top-line growth for first-quarter fiscal 2026 amid earnings decline and increased SG&A and operating expenses.